Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1746473 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.05Day −1.87%Mkt cap $65M1Y −28.1%Off 52W high −46.2%Vol (1Y) 56.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,541 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.6% of sh out |
| Days to cover3.3d |
| 13F net flow (QoQ)+7.08% |
| Top-10 13F concentration55.1% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$113.2M |
| ROE−61.5% |
| Debt / equity0.00× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−13.9% |
| 1Y−28.1% |
| 3Y−94.1% |
| 5Y−95.5% |
| Since incept. (ann.)−38.7% |
Total return through 2026-07-29 · series begins 2020-06-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)56.0% |
| Ann. volatility (3Y)82.0% |
| Sharpe (1Y)−0.48 |
| Sharpe (3Y)−0.62 |
| Max drawdown (1Y)−43.9% |
| Max drawdown (3Y)−94.8% |
| Beta (3Y vs SPY)1.19 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6.1M | $8M | 9.92% | +0.0% |
| CITADEL ADVISORS LLC | 3.2M | $4M | 5.21% | +24.9% |
| Blue Owl Capital Holdings LP | 3.0M | $4M | 4.80% | +0.0% |
| ADAR1 Capital Management, LLC | 2.6M | $3M | 4.17% | +3402.0% |
| ACADIAN ASSET MANAGEMENT LLC | 2.4M | $3M | 3.90% | +2.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $3M | 3.78% | new |
| TWO SIGMA INVESTMENTS, LP | 2.3M | $3M | 3.64% | +136.4% |
| Monaco Asset Management SAM | 1.9M | $2M | 3.13% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.32 | — | — | — |
| 2025-09-30 | 2025-11-06 | −$0.43 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$0.71 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$0.92 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
